What is the renal dosing for cephalexin (Keflex) in patients with urinary tract infection (UTI) and impaired renal function?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 15, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Renal Dosing of Cephalexin (Keflex) for UTI

For patients with creatinine clearance <30 mL/min, reduce cephalexin dosing to 250-500 mg every 12 hours rather than the standard every 6-hour regimen, as the drug is primarily renally cleared and accumulation can occur with impaired kidney function. 1, 2

Standard Dosing in Normal Renal Function

  • The typical dose for UTI is cephalexin 500 mg four times daily (every 6 hours) for 7 days in patients with normal renal function 3, 4
  • Recent evidence supports that 500 mg twice daily may be equally effective for uncomplicated UTIs, with no difference in treatment failure rates (12.7% vs 17%, P=0.343) compared to four-times-daily dosing 4
  • Cephalexin achieves urinary concentrations of 500-1000 mcg/mL following 250-500 mg oral doses, far exceeding the minimum inhibitory concentration for common uropathogens 2

Renal Dosing Adjustments

The critical threshold for dose adjustment is creatinine clearance <30 mL/min 2:

  • CrCl ≥30 mL/min: Use standard dosing (500 mg every 6-12 hours) 2
  • CrCl <30 mL/min: Reduce dosage proportionally to the degree of renal impairment; typical adjustment is 250-500 mg every 12 hours 2
  • Anephric patients: Single doses of 250-500 mg result in high, prolonged serum concentrations with peak levels within 1 hour (though delayed absorption up to 12 hours can occur in some patients) 5

Pharmacokinetic Considerations in Renal Impairment

  • Cephalexin is 70-100% excreted unchanged in urine within 6-8 hours after each dose 2
  • The drug is cleared primarily by glomerular filtration and tubular secretion 6
  • Even in patients with impaired renal function, urinary concentrations remain adequate for treating most UTIs caused by E. coli, Klebsiella, and Proteus mirabilis 5
  • Hemodialysis removes approximately 58% of cephalexin over 6 hours, so dosing should occur after dialysis 5

Practical Dosing Algorithm

Step 1: Calculate creatinine clearance 1, 2:

  • Use Cockcroft-Gault equation or measured creatinine clearance
  • Serum creatinine alone may underestimate degree of impairment

Step 2: Adjust dose based on renal function 2:

  • CrCl >50 mL/min: 500 mg every 6 hours OR 500 mg every 12 hours
  • CrCl 30-50 mL/min: 500 mg every 8-12 hours
  • CrCl 10-30 mL/min: 250-500 mg every 12 hours
  • CrCl <10 mL/min: 250 mg every 12-24 hours

Step 3: For hemodialysis patients 5:

  • Administer dose after dialysis session
  • Use 250-500 mg every 12-24 hours on non-dialysis days

Important Caveats and Monitoring

  • Careful clinical observation and laboratory monitoring are essential in patients with markedly impaired renal function, as safe dosage may be lower than usually recommended 1
  • Monitor for signs of drug accumulation, particularly in elderly patients who may have reduced renal function despite normal serum creatinine 2
  • Cephalexin does not require dose adjustment for hepatic impairment as it undergoes no measurable metabolism 2
  • The drug interacts with metformin by inhibiting tubular secretion; careful monitoring and metformin dose adjustment may be needed in patients taking both medications 1

Treatment Duration

  • Minimum 7 days for uncomplicated UTI in both males and females 7, 3, 4
  • Consider 10-14 days for complicated UTIs or when prostatitis cannot be excluded in males 7
  • Obtain urine culture before starting therapy to guide definitive treatment 7

When Cephalexin May Not Be Appropriate

  • Avoid in patients with CrCl <10 mL/min if alternative agents are available, as urinary concentrations may be suboptimal 6
  • Not recommended for pyelonephritis as first-line therapy; fluoroquinolones or parenteral agents are preferred 8
  • Consider alternatives if local E. coli resistance to first-generation cephalosporins exceeds 20% 7

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.